Published in Eur Urol on January 01, 1988
Ureteroscopy and stones: Current status and future expectations. World J Nephrol (2014) 0.83
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis (1988) 1.15
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost (2004) 1.14
Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet (2000) 1.13
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report. Haemophilia (2010) 1.09
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). Blood (1989) 1.09
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat (2006) 1.08
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia (2009) 1.05
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. Haemophilia (2007) 1.02
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study. Aliment Pharmacol Ther (2009) 0.99
Epidemiology of haemophilia in Greece: an overview. Thromb Haemost (1994) 0.99
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol (2001) 0.96
Searching for West Nile virus (WNV) in Greece. Transfus Med (2009) 0.95
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol (1999) 0.90
Haemophilia B Leyden in Greece. Thromb Haemost (1986) 0.89
Raynaud's phenomenon: primary and secondary causes. Arch Surg (1979) 0.88
Lymphadenopathy associated virus in AIDS, lymphadenopathy associated syndrome, and classic Kaposi patients in Greece. Lancet (1984) 0.85
Marathon Run III: effects on coagulation, fibrinolysis, platelet aggregation and serum cortisol levels. A 3-year study. Thromb Haemost (1980) 0.84
Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. Am J Hypertens (2000) 0.83
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia (2011) 0.83
Jaundice and hepatitis B surface antigen and antibody in Greek haemophiliacs. Scand J Haematol Suppl (1977) 0.83
Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Vox Sang (2007) 0.82
Marathon run II: Effects on platelet aggregation. Thromb Haemost (1977) 0.82
[Study of a case of congenital deficiency of factor 13 (FSF)]. Thromb Diath Haemorrh (1965) 0.81
Haemostasis balance disorders in patients with essential hypertension. Thromb Res (1997) 0.81
Factor XIII(A) subunit deficiency due to a homozygous 13-base pair deletion in exon 3 of the A subunit gene. Am J Hematol (1996) 0.81
HLA antigens as predictors of disease progression in HIV-infected haemophilia patients (a 22 years' follow up). Haemophilia (2005) 0.80
Extracorporeal shockwave lithotripsy or extracorporeal piezoelectric lithotripsy? Comparison of costs and results. Br J Urol (1991) 0.80
Management of haemophilia in Greece. Thromb Haemost (1976) 0.80
Concurrent hepatitis B, delta and human immunodeficiency virus infection in hemophiliacs. Thromb Haemost (1987) 0.79
High frequency of HLA-DR5 in Greek patients with haemophilia A and haemophilia B. Tissue Antigens (1986) 0.79
Prevalence and genotypic distribution of TT virus in Athens, Greece. J Med Virol (2001) 0.79
Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.79
Application of risk management techniques for the remediation of an old mining site in Greece. Waste Manag (2009) 0.78
Marathon run I: effects on blood coagulation and fibrinolysis. Thromb Haemost (1977) 0.78
Scoliosis by acquired rib fusion after thoracotomy in infancy. Eur Spine J (1993) 0.78
Significance of immune status, genotype and viral load in the severity of chronic hepatitis C in HIV infected haemophilia patients. Haemophilia (2002) 0.78
The prognostic value of p53 and DNA ploidy following radical prostatectomy. World J Urol (2003) 0.77
Methodology, results and complications in 2000 extracorporeal shock wave lithotripsy procedures. Br J Urol (1988) 0.77
Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients. Haemophilia (2005) 0.77
Increased microvascular network in bone marrow of HIV-positive haemophilic patients. HIV Med (2004) 0.77
Long lasting sitting position and haemostasis. Thromb Haemost (1986) 0.77
Association between HLA antigens and progression of HIV infection in Greek haemophiliacs. Dis Markers (1993) 0.77
Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece. Virus Res (2002) 0.77
Carrier detection in hemophilia using pedigree analysis coagulation tests and DNA probes. Nouv Rev Fr Hematol (1989) 0.77
Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution. Stat Med (2001) 0.77
Enzymatic evaluation of renal damage caused by different therapeutic procedures for kidney stone disease. Int Urol Nephrol (1995) 0.76
Myelodysplastic features in patients with long-term HIV infection and haemophilia. Haemophilia (2001) 0.76
Variations in factor VIII during the menstrual cycle in normal women. N Engl J Med (1980) 0.76
Risk of HIV infection and AIDS in women and girls with coagulation disorders. AIDS (1994) 0.76
Heterosexual transmission of HIV in Greece. AIDS Res Hum Retroviruses (1988) 0.75
Eosinophilia in patients undergoing dialysis. Br Med J (Clin Res Ed) (1982) 0.75
Allele frequency of the CCR5 mutant chemokine receptor in Greek Caucasians. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.75
A study of psycho-social aspects of both haemophiliacs and carriers in Greece. Scand J Haematol Suppl (1984) 0.75
[Obstruction of the ureter after extracorporeal lithotripsy in cases of a single kidney]. Presse Med (1987) 0.75
Thrombophilic factors in patients with Syndrome X. Thromb Res (2000) 0.75
Effects of prolonged sitting on the mechanism of hemostasis--the changes of FVII:C and the cold activated FVII:C. Thromb Haemost (1985) 0.75
Genotypic characterization of human immunodeficiency virus type 1 in Greece. Multicentre Study on HIV-1 Heterogeneity. AIDS Res Hum Retroviruses (1998) 0.75
Haemophlic arthropathy surveyed with whole-body gamma-camera scinitgraphy. Acta Orthop Scand (1976) 0.75
Does protease inhibitor treatment induce increased bleeding tendency in haemophilia? Haemophilia (1998) 0.75
Lipoproteins, triglycerides, cholesterol changes after prostatic carcinoma treatment. Acta Urol Belg (1982) 0.75
A novel insertion mutation (1286insC) in exon 9 of the factor XIII-A subunit gene. Blood Coagul Fibrinolysis (1998) 0.75
Value of the prostatic LDH levels in the diagnosis of bacterial prostatitis. Eur Urol (1989) 0.75
Hemostatic function and carotid artery disease. Int Angiol (2004) 0.75
Antibody responses to hepatitis C virus by second-generation immunoassays in a cohort of patients with bleeding disorders. Vox Sang (1992) 0.75
The importance of preoperative investigations of bleeding tendency in E.N.T. operations. Int Surg (1967) 0.75
Vascular surgery in a hemophiliac. Am J Surg (1981) 0.75
Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C in patients with congenital coagulation disorders. Acta Haematol (2008) 0.75
Early plasmapheresis in patients with thrombotic thrombocytopenic purpura. Crit Care Med (1992) 0.75
Neuropsychological assessment of HIV-seropositive haemophiliacs. AIDS (1991) 0.75
Eosinophilia in patients undergoing regular hemodialysis. Int J Artif Organs (1983) 0.75
Prevalence of the FVQ506 mutation in the Hellenic population. Thromb Haemost (1996) 0.75
[Genetic markers in papillary cancer of the bladder]. J Urol (Paris) (1983) 0.75
Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia. Am J Hematol (1997) 0.75
Increased heart rate and haemostatic balance disorders pre-exist the established hypertension. Thromb Haemost (1999) 0.75
Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs. AIDS Res (1986) 0.75
Virological and immunological response to HAART therapy in a community-based cohort of HIV-1-positive individuals. HIV Clin Trials (2001) 0.75
Urothelial tumors of the bladder. Child Nephrol Urol (1992) 0.75
A comparison of the availability and content of genetic counseling as perceived by hemophilic men and carriers in the U.S.A., Canada, Scotland, and Greece. Am J Med Genet (1986) 0.75
[The study of hemophilia carriers in Greece]. Bibl Haematol (1966) 0.75
HIV seropositivity in Greek blood donors (1985-1990) Vox Sang (1991) 0.75
Isoimmunization in haemophiliacs. Scand J Haematol Suppl (1977) 0.75
Effects of glibenclamide on postprandial coagulation activation. Nutr Metab Cardiovasc Dis (1999) 0.75
Metabolic disturbances in cystinuria. Eur Urol (1982) 0.75
[Blood coagulation studies in dysfunctional uterine hemorrhages]. Akush Ginekol (Sofiia) (1981) 0.75
Acute prostatitis: which antibiotic to use first? Chemioterapia (1987) 0.75
Marathon run: effect on antithrombin III. Thromb Haemost (1978) 0.75